MRI Techniques For Early-stage Detection Of Cancer
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 24-001835
Sponsor Protocol Number: 24-001835
About this study
The purpose of this study is to develop 7T MRI techniques for early-stage detection of cancer, using both hydrogen (1H) and deuterium (2H) imaging.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Exclusion Criteria:
implanted active devices such as cardiac defibrillators/pacemakers, deep brain stimulators, vagus nerve stimulators, intrathecal pumps, cochlear implants
devices, or residual parts thereof left in the body such as cardiac pacer wires, which provide life assist, bone growth or pain management
structural support devices, screws, or wires in bone that are near the spinal cord or temperature sensitive organs
reconstructive metallic implants near the orbits
external devices, medicinal patches, piercings, jewelry, clothing or hair accessories (such as wigs, weaves and extensions) within to the radiofrequency coil that cannot be removed from the body
pregnancy
tattoos located within to the radiofrequency coil
metallic fragment in the eye
fever / elevated temperature
suffer from claustrophobia
for 2H deuterium-MRI exams, subjects who are in a current diabetic ketoacidosis or hyperosmolar hyperglycemic state will be excluded from participation in this study.
For 1H hydrogen MRI in subjects receiving a gadolinium-based contrast agent, subjects with a known allergy to these agents will be excluded from participation in this study.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 2/14/2024. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Andrew Fagan, Ph.D. |
Open for enrollment |
|
More information
Publications
Publications are currently not available